Advent Life Sciences Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 73
  • Portfolio
  • 23
  • Exits
  • 37
Exits

Advent Life Sciences General Information

Description

Founded in 2009, Advent Life Sciences is a venture capital firm based in London, England. The firm seeks to invest in early and mid-stage life sciences firms. The firm focuses on new drug discovery, small molecules, biologics and new modalities, med tech, enabling technologies and vaccines.

Contact Information

Website
www.adventls.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 158-160 North Gower Street
  • London NW1 2ND
  • England, United Kingdom
+44 020 0000 0000

Advent Life Sciences Investments (73)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Highlight Therapeutics 05-Feb-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2
000000 00000000000 13-Oct-2020 00000 00000 000.00 Drug Discovery Product Development 000000 000000 00.0
000 12-Aug-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 000000 0000000
00000 000000000000 31-Jul-2020 00000 00000 00.000 Drug Discovery Generating Revenue
000000 00000000000 09-Apr-2020 00000 00000 00.00 Drug Discovery Generating Revenue 000000 000000 00.0
00000000 000000000 07-Apr-2020 00000 00000 00.000 Drug Discovery Generating Revenue 000000 000000 00.0
000 000000000000 02-Apr-2020 0000 00000 000.00 Drug Discovery Generating Revenue 0000 00000 00.0
00000 000000000000 18-Feb-2020 0000 00000 00.000 Drug Discovery Startup
MiroBio 07-Oct-2019 Early Stage VC 000.00 Biotechnology Startup 0000000 00000 00
Acutus Medical 20-Jun-2019 Later Stage VC 00000 Diagnostic Equipment Generating Revenue/Not Profitable 0000000 00000 00
You’re viewing 10 of 73 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advent Life Sciences Exits (37)

Company Name Exit Date Exit Type Exit Size
Tridek-One 11-Jan-2021 Out of Business
000000 00000000000 26-Oct-2020 000000 0000000000 000.00
00000 000000000000 09-Sep-2020 000000000000000000 00000
000000 0000000 06-Aug-2020 000 00000
0000000 0000000000 01-Jan-2020 000 00 00000000
00000000 01-Jul-2019 000 00 00000000
0000000 0000000000 31-Oct-2018 000 00000
000000 00000000000 25-May-2018 000 0000
TandemLife 04-Apr-2018 Merger/Acquisition 00000
Aravive Inc 30-Jun-2017 Secondary Transaction - Open Market
You’re viewing 10 of 37 exits. Get the full list »

Advent Life Sciences Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Advent Life Sciences‘s full profile, request access.

Request a free trial

Advent Life Sciences Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Advent Life Sciences Team (20)

Name Title Deals Funds Boards Office
Kaasim Mahmood General Partner 0 0 0 London, United Kingdom
Rajesh Parekh Ph.D General Partner 00 0 00 London, United Kingdom
Shahzad Malik MD General Partner 00 0 0 London, United Kingdom
Donald Drakeman Ph.D Venture Partner London, United Kingdom
Karen LaRochelle Venture Partner London, United Kingdom
You’re viewing 5 of 20 team members. Get the full list »

Advent Life Sciences Co-Investors (77)

Name With Exits Lead Partner Series Industry
Novo Holdings 3 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Canaan Partners 0 0 Series chart Industry bar
FORBION 0 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
You’re viewing 5 of 77 co-investors. Get the full list »